Postulated direct renoprotective effects of GLP-1 receptor agonists: human physiology studies Gut-kidney axis: kidney sodium handling
Kim, D., Hwang, J.F.H., and Fendrick, A.M., Balancing innovation and affordability in anti-obesity medications: the role of an alternative weight-maintenance program, Health Affairs Scholar , May 2, 2024
Fat supports hormonal homeostasis, says Dr
If you notice these symptoms, especially after periods of vomiting or diarrhea, seek medical attention
GLP-1 stands for glucagon-like peptide-1 , a hormone your body naturally produces
Some analysts and industry observers expect that an FDA decision may not occur until late 2026 or 2027, assuming all safety and efficacy endpoints are met